December 11, 2006 — The US Food and Drug Administration (FDA) has approved a polytetrafluoroethylene-heparin vascular graft for use in the treatment of peripheral artery disease, a myocardial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback